[
  {
    "ts": null,
    "headline": "Why The Narrative Around Cardinal Health (CAH) Is Shifting With Fresh Targets And Fair Value Assumptions",
    "summary": "The fair value estimate for Cardinal Health has shifted from about US$230.27 to roughly US$243.07 per share, reflecting updated assumptions that use a slightly higher discount rate and a lower revenue growth outlook. Even with that softer growth assumption, recent analyst commentary around guidance, specialty expansion, and core distribution resilience has supported a higher price target. Stay tuned to see how you can keep on top of these moving assumptions and the evolving narrative around...",
    "url": "https://finnhub.io/api/news?id=affd56869ded5991eba3173d7ad70c85b09f626512172a804bae36743368b3bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770847751,
      "headline": "Why The Narrative Around Cardinal Health (CAH) Is Shifting With Fresh Targets And Fair Value Assumptions",
      "id": 139050655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "The fair value estimate for Cardinal Health has shifted from about US$230.27 to roughly US$243.07 per share, reflecting updated assumptions that use a slightly higher discount rate and a lower revenue growth outlook. Even with that softer growth assumption, recent analyst commentary around guidance, specialty expansion, and core distribution resilience has supported a higher price target. Stay tuned to see how you can keep on top of these moving assumptions and the evolving narrative around...",
      "url": "https://finnhub.io/api/news?id=affd56869ded5991eba3173d7ad70c85b09f626512172a804bae36743368b3bf"
    }
  },
  {
    "ts": null,
    "headline": "BD Merges Biosciences & Diagnostics Business With Waters",
    "summary": "BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.",
    "url": "https://finnhub.io/api/news?id=8aa67feffa66822cd5f20e85d99a08216364ba8db914f75972e7acad8a414154",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770834840,
      "headline": "BD Merges Biosciences & Diagnostics Business With Waters",
      "id": 139049621,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.",
      "url": "https://finnhub.io/api/news?id=8aa67feffa66822cd5f20e85d99a08216364ba8db914f75972e7acad8a414154"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
    "summary": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=fc318b17de58d6691793ab0fcf5885d1a9330162a3a91cf0bd4b3c4e88e3fbd3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770828540,
      "headline": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
      "id": 139067458,
      "image": "",
      "related": "CAH",
      "source": "MarketWatch",
      "summary": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=fc318b17de58d6691793ab0fcf5885d1a9330162a3a91cf0bd4b3c4e88e3fbd3"
    }
  }
]